comparemela.com

Latest Breaking News On - Lifesci advisors - Page 14 : comparemela.com

NKGen Biotech Announces Upcoming Presentation on Autologous

NKGen Biotech Announces Upcoming Presentation on Autologous
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Nanjing
Jiangsu
China
California
United-states
Denise-chua
Kevin-gardner
Chris-calabrese
Lifesci-advisors
Corporate-communications
Securities-exchange
Nasdaq

EDAP TMS S A : Reports First Quarter 2024 Financial Results - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER .

Vaulx-en-velin
Rhôalpes
France
New-york
United-states
Texas
Washington
San-antonio
America
American
Poudrette-lamartine
John-fraunces

NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition

NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Nanjing
Jiangsu
China
United-states
California
Chris-calabrese
Kevin-gardner
Denise-chua
International-cell-gene-therapy-china-summit-exhibition
Lifesci-advisors
Globe-newswire-nkgen-biotech-inc
Exchange-commission

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

Completed acquisition of Trawsfynydd and concurrent $14 million Capital Raise Excellent pipeline progress, led by candidates for COVID 19, influenza, and oncology programs Poised to initiate Phase 2.

Australia
Traws-pharma
Mark-guerin
Bruce-mackle
Werner-cautreels
Torrey-pines
Securities-exchange
Exchange-commission
Lifesci-advisors
Traws-pharma-inc
Chief-executive-officer
Proprietary-portfolio-highlights

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies , a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced that it will report.

Rehovot
Hamerkaz
Israel
Dan-ferry-at-lifesci-advisors
Allergan
Plant-biotechnologies
Collplant-investor
Dan-ferry
Lifesci-advisors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.